Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack )

Send Inquiry

Request To Call Back

Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack )

Name: Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack )
Brand: K. K. PHARMA SOLUTIONS
Price: 4000.0 INR
Availability: InStock

Price 4000.0 INR/ Piece

Get a Price/Quote

MOQ : 1 Piece

Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack ) Specification

Packaging Type
Boxed Combipack

Pacakaging (Quantity Per Box)
6 tablets (4 Nirmatrelvir 150mg, 2 Ritonavir 100mg)

Salt Composition
Nirmatrelvir & Ritonavir

Brand Name
Paxobrook Tab

Dosage Form
Tablet

Origin of Medicine
India

Indication
Treatment of mild to moderate COVID-19 in high-risk patients

Life Span
24 months from date of manufacture

Drug Type
Antiviral Combination

Ingredients
Nirmatrelvir 150mg, Ritonavir 100mg

Physical Form
Tablets (Combipack)

Function
Antiviral therapy for COVID-19

Recommended For
Adults at risk of progressing to severe COVID-19

Dosage
As directed by physician

Dosage Guidelines
Take orally, as per medical advice

Suitable For
Adults only

Quantity
1 Combipack

Storage Instructions
Store below 30C, protect from moisture

Box Dimensions
Standard pharmaceutical combipack size

Administration Route
Oral

Regulatory Status
Approved under Emergency Use Authorization

Manufactured By
Brookwell Healthcare Pvt. Ltd.

Warning
Not recommended for use in pediatric patients, pregnant or breastfeeding women unless prescribed

Prescription Required
Yes

Mode of Action
Protease inhibitor; inhibits SARS-CoV-2 replication

Colour of Tablets
Nirmatrelvir: Pink, Ritonavir: White

Therapeutic Class
Antiviral

Batch Number & Expiry
Printed on strip and box

Contraindications
Known hypersensitivity to Nirmatrelvir, Ritonavir, or any excipients

Drug Interactions
May interact with other medications; consult physician

About Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack )

Paxobrook tablets, a generic version of the brand-name drug Paxlovid, are used to treat mild-to-moderate coronavirus disease (COVID-19) in people who are at high risk of developing severe symptoms that could lead to hospitalization or death

How Does Paxobrook Tab Work?

Paxobrook Tab contains Nirmatrelvir and Ritonavir, a combination of protease inhibitors. These tablets block a key enzyme needed for SARS-CoV-2, the virus causing COVID-19, to replicate in the body. By preventing viral multiplication, Paxobrook Tab helps reduce the severity and progression of COVID-19 in high-risk adults when taken as directed by a physician.

Who Should Use Paxobrook Tab?

This medication is recommended for adults diagnosed with mild to moderate COVID-19 who are at increased risk of progressing to severe disease. Paxobrook Tab is not recommended for pediatric patients, pregnant or breastfeeding women unless specifically directed by a healthcare provider. Patients must have no known hypersensitivity to either Nirmatrelvir, Ritonavir, or any related excipients.

How Should Paxobrook Tab Be Taken?

Paxobrook Tab should be taken orally, strictly following the dosage and schedule provided by your physician. The standard combipack contains six tablets (four Nirmatrelvir, two Ritonavir). Swallow the tablets whole with water and avoid exceeding the prescribed amount. It is important to complete the entire course for optimal antiviral benefits.

FAQ's of Paxobrook Tab (Nirmatrelvir tablet 150mg & Ritonavir Tab Ip 100mg Combipack ):

Q: What is the main benefit of using Paxobrook Tab?

A: Paxobrook Tab helps reduce the severity and risk of progression in high-risk adults diagnosed with mild to moderate COVID-19 by inhibiting viral replication early in the infection.

Q: How should Paxobrook Tab be taken and in what dosage?

A: Paxobrook Tab should be taken orally as prescribed by your physician. The standard pack contains 4 Nirmatrelvir (pink) and 2 Ritonavir (white) tablets; follow your doctor's dosage instructions precisely and never adjust the dose without medical advice.

Q: Who should not use Paxobrook Tab?

A: This medication is contraindicated in individuals with known hypersensitivity to Nirmatrelvir, Ritonavir, or any excipients. It is not recommended for pediatric patients, pregnant or breastfeeding women unless prescribed by a healthcare provider.

Q: What should I do if I am taking other medications?

A: Inform your physician about all other medicines and supplements you are taking, as Nirmatrelvir and Ritonavir may interact with several drugs. Your doctor will assess for potential interactions and adjust your therapy as needed.

Q: Where should Paxobrook Tab be stored?

A: Store Paxobrook Tab in its original combipack below 30C, away from moisture and direct sunlight to maintain its potency and effectiveness.

Q: What are the physical characteristics of the tablets?

A: The combipack includes two types of tablets: Nirmatrelvir, which are pink, and Ritonavir, which are white, making identification straightforward during the dosing process.

Tell us about your requirement